{
     "PMID": "27043274",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170227",
     "LR": "20170227",
     "IS": "1872-7123 (Electronic) 0165-1781 (Linking)",
     "VI": "239",
     "DP": "2016 May 30",
     "TI": "Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine.",
     "PG": "281-3",
     "LID": "10.1016/j.psychres.2016.03.034 [doi] S0165-1781(15)30646-6 [pii]",
     "AB": "Clinical use of the rapid antidepressant drug ketamine is limited, due to psychotomimetic side effects. R-ketamine appears to be a potent, long-lasting and safer antidepressant, relative to S-ketamine (esketamine), since it is free of psychotomimetic side effects. Repeated, intermittent administration of esketamine (10mg/kg, once per week for 8-weeks), but not R-ketamine, caused loss of parvalbumin (PV)-immunoreactivity in the medial prefrontal cortex and hippocampus of mouse brains, regions associated with psychosis. This study suggests that repeated intermittent use of R-ketamine is safer than esketamine in the treatment of depression.",
     "CI": [
          "Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved."
     ],
     "FAU": [
          "Yang, Chun",
          "Han, Mei",
          "Zhang, Ji-Chun",
          "Ren, Qian",
          "Hashimoto, Kenji"
     ],
     "AU": [
          "Yang C",
          "Han M",
          "Zhang JC",
          "Ren Q",
          "Hashimoto K"
     ],
     "AD": "Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan. Electronic address: hashimoto@faculty.chiba-u.jp.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20160324",
     "PL": "Ireland",
     "TA": "Psychiatry Res",
     "JT": "Psychiatry research",
     "JID": "7911385",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Parvalbumins)",
          "690G0D6V8H (Ketamine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/administration & dosage/adverse effects/*pharmacology",
          "Hippocampus/*drug effects",
          "Immunohistochemistry",
          "Ketamine/administration & dosage/adverse effects/*pharmacology",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Parvalbumins/*drug effects",
          "Prefrontal Cortex/*drug effects"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Esketamine",
          "Parvalbumin",
          "R-ketamine"
     ],
     "EDAT": "2016/04/05 06:00",
     "MHDA": "2017/02/28 06:00",
     "CRDT": [
          "2016/04/05 06:00"
     ],
     "PHST": [
          "2015/11/08 00:00 [received]",
          "2016/02/19 00:00 [revised]",
          "2016/03/20 00:00 [accepted]",
          "2016/04/05 06:00 [entrez]",
          "2016/04/05 06:00 [pubmed]",
          "2017/02/28 06:00 [medline]"
     ],
     "AID": [
          "S0165-1781(15)30646-6 [pii]",
          "10.1016/j.psychres.2016.03.034 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Psychiatry Res. 2016 May 30;239:281-3. doi: 10.1016/j.psychres.2016.03.034. Epub 2016 Mar 24.",
     "term": "hippocampus"
}